Ranked in 2 Practice Areas
Ranked in Guides

About

Provided by Jeffrey Ding

Greater China Region

Practice Areas

MR. DING IS A PARTNER IN THE BEIJING OFFICE OF THE FIRM. MR. DING SPECIALIZES IN GENERAL CORPORATE MATTERS, M&A, PRIVATE EQUITY AND CAPITAL MARKETS. HE HAS ALSO ADVISED ON MANY CROSS-BORDER ACQUISITIONS, PUBLIC OFFERINGS, PRIVATE PLACEMENTS, AND JOINT VENTURE TRANSACTIONS.

Career

Mr. Ding has more than 20 years of experience practicing law. He has represented numerous international clients, including multinational corporations, financial institutions and private equity funds, in their investment projects in China. He has also represented clients in many US and HK IPOs and A-share deals.

Before joining Fangda Partners, Mr. Ding worked as legal counsel for a Fortune 500 company. He has been named a leading lawyer by Chambers and Partners, International Financial Law Review, China Law and Practice and other professional journals in the areas of Corporate/M&A and Capital Markets every year since 2007.

Personal

Mr. Ding has more than 20 years of experience practicing law. He has represented numerous international clients, including multinational corporations, financial institutions and private equity funds, in their investment projects in China. He has also represented clients in many US and HK IPOs and A-share deals.

Education

Peking University School of Law

LL.B

Experience

M&A

Represented Zoomlion Heavy Industry, in its acquisition of the controlling stake in ShenZhen RoadRover Technology

Advised China National Chemical Corporation as PRC counsel on its tender offer for Syngenta’s 100% outstanding shares at the price of USD 465 per share, with an aggregate valuation over USD 43 billion

Represented Kingsoft Cloud in its strategic acquisition of a controlling interest in Camelot, a China-based IT service and solution provider

Represented MBK Partners in its acquisition and privatization of CAR Inc. (HK Stock Code: 00699), the largest car rental company in China

Advised the investor group consisting of ANTA, FountainVest and others in their proposed acquisition of Amer Sports Corporation, a sporting goods company with internationally recognized brands

Acted for HP in its RMB 18.85 billion sale of 51% of the total share capital of H3C Technologies Co., Ltd. to Unisplendour Corporation Limited, a company listed on the Shenzhen Stock Exchange

Represented the investor consortium led by MBK Partners in its privatization of eHi Car Services Limited, a leading car rental and car services company in China

Represented BeiGene in Amgen Inc. in its USD 2.7 billion strategic investment in BeiGene

Represented TPV Technology Limited, a world-renowned leader in smart display manufacturing, in Nanjing Huadong Electronic Information & Technology’s RMB 13.1 billion acquisition of TPV Technology

Represented Ant Financial in its RMB 3.3 billion acquisition of Hundsun Technologies Inc.

Represented BeiGene in Celgene’s strategic investment in BeiGene

Represented China Music Corporation Music in its strategic merger with Tencent Music

Private equity and venture capital investment

Represented China Reform Holdings Corporation Ltd. in its strategic investment in China Orient Asset Management Co., Ltd.

Represented Alibaba and Aspex Master Fund in the pre-IPO investments of Xpeng, one of China’s leading smart electric vehicle companies

Represented Primavera Capital and Ant Financial Services in their announced investment of USD 460 million in Yum! China Holdings Inc.

Represented Delta Airlines in its HKD 3.48 billion subscription of 465,910,000 H shares issued by China Eastern Airlines Corporation

Represented Goldman Sachs in its strategic investment in China Huarong Asset Management Co., Ltd.

Represented UBS AG in its pre-IPO investment in China Cinda Asset Management Co., Ltd.

Represented Goldman Sachs in its strategic acquisition of 12.02% equity of Taikang Insurance Group

Represented a number of private equity firms active in China, including PAG, Hillhouse, TPG, DST, Primavera Capital, MBK, and CDH Investments, in participating in investment and financing transactions in Greater China

Onshore and offshore issuance

Advised nearly 30 companies in listing on the Hong Kong Stock Exchange, including Alibaba Group (stock code: 9988), BeiGene (stock code: 6160), Xpeng (stock code: 9868), New Horizon Health (stock code: 6606), SITC (stock code: 1697), China Development Bank Financial Leasing Co., Ltd., (stock code: 1606), CIIC (stock code: 6819), Hanhua Finance (stock code: 3903), Zoomlion (stock code: 1157), Huahong Group (stock code: 1347), HKBN (stock code: 1310), Linekong Interactive Group (stock code: 8267), Kingsoft (stock code: 3888), Shimao Group (stock code: 0813), PRADA Group (stock code: 1913), Samsonite (stock code: 1910), Hsin Chong Group (stock code: 0404), Fast Retailing (stock code: 6288), and O-Net (stock code: 0877)

Advised nearly 40 companies in listing on NYSE/NASDAQ, including Alibaba Group (stock code: BABA), Xpeng (stock code: XPEV), Kingsoft Cloud Holdings Ltd (stock code: KC), BeiGene (stock code: BGNE), Zepp Health (stock code: ZEPP), Rise Education (stock code: REDU), iClick Interactive (stock code: ICLK), GDS (stock code: GDS), Xunlei Limited (stock code: XNET), AutoNavi Holdings (stock code: AMAP), Jumei International (stock code: JMEI), Tuniu (stock code: TOUR), Autohome Inc. (stock code: ATHM), JOYY (stock code: YY), Beyond Spring (stock code: BYSI), Focus Media (stock code: FMCN), Vipshop (stock code: VIPS), Sofang (stock code: SFUN), Mingyang Smart Energy (stock code: MY), Pactera EDGE (stock code: PACT), and Yingli Group (stock code: YGE)

Advised leading companies in listing A Shares or in refinancing transactions, including: BeiGene (stock code: 688235.SH); Bank of Chongqing (stock code: 601963.SH); Megvii; InnoCare Pharma Limited; COWealth Medical (stock code: 603122.SH); PICC; COSCO Shipping; GAC Group; Baoshan Iron & Steel Co., Ltd.; Yunnan Yuntianhua Co., Ltd. (stock code: 600096.SH); ZTT (stock code: 600522.SH); Zoomlion (stock code: 000157.SZ); Focus Media (stock code: 002027.SZ); Shiji Group (stock code: 002153.SZ); and Huayi Brothers Media Group (stock code: 300027.SZ).

Chambers Review

Provided by Chambers

Greater China Region

Capital Markets: Debt & Equity (PRC Firms) - China
2
Band 2

Jeffrey Ding is well reputed for handling both domestic and overseas listings. He is well versed in handling equity offerings for clients in the financial, pharmaceutical and software industries.

丁继栋律师以处理国内及海外上市业务而闻名。他精通处理金融、制药及软件行业的股权发行。

Discover other Lawyers at
Fangda Partners

Provided by Chambers
Filter by
Band

China

Aviation: Finance (PRC Firms)

Ge Tan
1
Ge Tan
1
Band 1
Yang Song
Associates to watch
Banking & Finance (PRC Firms)

Zheng Xie
E
Zheng Xie
E
Eminent Practitioners
Stanley Chen
2
Stanley Chen
2
Band 2
Joyce Zhou
U
Joyce Zhou
U
Up and Coming
Rock Wang
U
Rock Wang
U
Up and Coming
Capital Markets: Debt & Equity (PRC Firms)

Jeffrey Ding
2
Jeffrey Ding
2
Band 2
Qier Tang
2
Qier Tang
2
Band 2
Christine Chen
3
Christine Chen
3
Band 3
Xueyan Jiang
4
Xueyan Jiang
4
Band 4
Capital Markets: Debt (International Firms)

Christine Chen
4
Christine Chen
4
Band 4
Capital Markets: Equity (International Firms)

Colin Law
5
Colin Law
5
Band 5
Capital Markets: Securitisation & Derivatives (PRC Firms)

Dong Wu
2
Dong Wu
2
Band 2
Yan Yan
3
Yan Yan
3
Band 3
Competition/Antitrust (PRC Firms)

Michael Han
1
Michael Han
1
Band 1
Caroline Huang
3
Caroline Huang
3
Band 3
Jin Wang
U
Jin Wang
U
Up and Coming
Construction (PRC Firms)

Tony Xiang
U
Tony Xiang
U
Up and Coming
Corporate Investigations/Anti-Corruption (PRC Firms)

Kate Yin
1
Kate Yin
1
Band 1
Yanjun Zhuang
3
Yanjun Zhuang
3
Band 3
20 of 69 results